NCT03833297View on ClinicalTrials.gov

Monitoring the HePAtological TOXicity of Drugs (HePATOX)

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

February 4, 2020

Study Completion Date

April 4, 2023

Conditions
Liver DiseasesLiver DysfunctionLiver FailureHepatotoxicity
Interventions
DRUG

Drugs inducing hepatological toxicity

Drugs susceptible to induce hepatological toxicities

Trial Locations (1)

75013

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03833297 - Monitoring the HePAtological TOXicity of Drugs (HePATOX) | Biotech Hunter | Biotech Hunter